BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37725130)

  • 1. Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods-what's around the corner?
    Grahn A; Coleman JA; Eriksson Y; Gabrielsson S; Madsen JS; Tham E; Thomas K; Turney B; Uhlén P; Vollmer T; Zieger K; Osther PJS; Brehmer M
    World J Urol; 2023 Dec; 41(12):3405-3411. PubMed ID: 37725130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consultation on UTUC II Stockholm 2022: diagnostics, prognostication, and follow-up-where are we today?
    Sydén F; Baard J; Bultitude M; Keeley FX; Rouprêt M; Thomas K; Axelsson TA; Jaremko G; Jung H; Malm C; Proietti S; Osther PJS; Brehmer M
    World J Urol; 2023 Dec; 41(12):3395-3403. PubMed ID: 37540248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma.
    Fojecki G; Magnusson A; Traxer O; Baard J; Osther PJS; Jaremko G; Seitz C; Knoll T; Giusti G; Brehmer M
    World J Urol; 2019 Nov; 37(11):2271-2278. PubMed ID: 30915526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic profile - a possible diagnostic and prognostic marker in upper tract urothelial carcinoma.
    Grahn A; Eisfeldt J; Malm C; Foroughi Asl H; Jaremko G; Tham E; Brehmer M
    BJU Int; 2022 Jul; 130(1):92-101. PubMed ID: 34375486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.
    Yates DR; Catto JW
    World J Urol; 2013 Feb; 31(1):21-9. PubMed ID: 22986906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does urinary cytology have a role in haematuria investigations?
    Tan WS; Sarpong R; Khetrapal P; Rodney S; Mostafid H; Cresswell J; Watson D; Rane A; Hicks J; Hellawell G; Davies M; Srirangam SJ; Dawson L; Payne D; Williams N; Brew-Graves C; Feber A; Kelly JD;
    BJU Int; 2019 Jan; 123(1):74-81. PubMed ID: 30003675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up.
    Hasan MN; Rouprêt M; Keeley F; Cracco C; Jones R; Straub M; Traxer O; Osther PJS; Brehmer M
    World J Urol; 2019 Nov; 37(11):2289-2296. PubMed ID: 30944969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review.
    van Doeveren T; van de Werken HJG; van Riet J; Aben KKH; van Leeuwen PJ; Zwarthoff EC; Boormans JL
    Urol Oncol; 2020 Jun; 38(6):590-598. PubMed ID: 32057596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.
    Petros FG; Choi W; Qi Y; Moss T; Li R; Su X; Guo CC; Czerniak B; Dinney C; McConkey DJ; Matin SF
    J Urol; 2021 Sep; 206(3):548-557. PubMed ID: 33881933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
    Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
    Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
    Rouprêt M; Babjuk M; Burger M; Capoun O; Cohen D; Compérat EM; Cowan NC; Dominguez-Escrig JL; Gontero P; Hugh Mostafid A; Palou J; Peyronnet B; Seisen T; Soukup V; Sylvester RJ; Rhijn BWGV; Zigeuner R; Shariat SF
    Eur Urol; 2021 Jan; 79(1):62-79. PubMed ID: 32593530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Fluorescences in Situ Hybridization Status in Excreted Urine Improve Diagnostic Efficacy for Upper Urinary Tract Urothelial Carcinomas.
    Tang F; Wang X; Liu T; Wang H; Wan Z; Fu Q; Zheng Z; Aersi M; Peng J
    Urol J; 2024 Mar; 21(2):107-113. PubMed ID: 38168059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.
    Bree KK; Hensley PJ; Brooks NA; Matulay J; Li R; Nogueras Gonzalez GM; Navai N; Grossman HB; Matin SF; Dinney CPN; Kamat AM
    BJU Int; 2021 Nov; 128(5):568-574. PubMed ID: 33484074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Characterization of Upper Tract Urothelial Carcinoma.
    Sfakianos JP; Cha EK; Iyer G; Scott SN; Zabor EC; Shah RH; Ren Q; Bagrodia A; Kim PH; Hakimi AA; Ostrovnaya I; Ramirez R; Hanrahan AJ; Desai NB; Sun A; Pinciroli P; Rosenberg JE; Dalbagni G; Schultz N; Bajorin DF; Reuter VE; Berger MF; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA
    Eur Urol; 2015 Dec; 68(6):970-7. PubMed ID: 26278805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.
    Rouprêt M; Seisen T; Birtle AJ; Capoun O; Compérat EM; Dominguez-Escrig JL; Gürses Andersson I; Liedberg F; Mariappan P; Hugh Mostafid A; Pradere B; van Rhijn BWG; Shariat SF; Rai BP; Soria F; Soukup V; Wood RG; Xylinas EN; Masson-Lecomte A; Gontero P
    Eur Urol; 2023 Jul; 84(1):49-64. PubMed ID: 36967359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
    Kates M; Badalato GM; Gupta M; McKiernan JM
    BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.